Magenta Medical Ltd. specializes in advanced medical technologies, particularly focusing on their Elevate™ percutaneous Left Ventricular Assist Device (pLVAD). This innovative device is designed as a low-profile, high-flow arterial pump that provides temporary circulatory support for patients undergoing high-risk coronary interventions. It is also intended for use in patients experiencing cardiogenic shock, a condition where the heart is unable to pump sufficient blood to meet the body's needs. The Elevate™ system aims to enhance patient outcomes during critical medical procedures by offering reliable and efficient mechanical support.

The Elevate™ pLVAD represents a significant advancement in percutaneous mechanical circulatory support, emphasizing both ease of use and effectiveness in emergency situations. By facilitating temporary support, the device allows healthcare providers to stabilize patients while they receive necessary interventions, ultimately improving survival rates and recovery times. Magenta Medical's commitment to innovation in cardiac care is evident in their focus on developing technologies that address urgent medical needs in high-risk scenarios.

Israel

Magenta is developing miniaturized catheter-mounted axial flow-pumps for mechanical circulatory support indications, based on Magenta's core technology of self-expanding impellers and pump heads. 
Our percutaneous Left Ventricular Assist Device (pLVAD) is a next-generation low-profile arterial pump, intended for temporary support of patients undergoing high-risk coronary interventions and the treatment of patients admitted with cardiogenic shock.

Magenta Medical Ltd.

Company Details